Supervision and examination of postgraduate students in Pharmaceutical Sciences

 

  • Asma Jumah (M.S), Examiner. Design, Synthesis, and Biological Evaluation of N-Substituted-4-Hydroxy-8-Methoxy-2-Quinolone-3-Carboxamides      as PI3Kα Inhibitors, 2018/2019. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Maha Awad (M.S), Supervisor. Shiff’s Bases: Synthesis, characterization, in vitro and in vivo biological evaluation as DPP-IV inhibitors, 2018/2019. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Amani Abu Sa’ed (M.S), Supervisor. Synthesis, characterization and biological evaluation of novel benzamides as CETP inhibitors, 2018/2019. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Ebtisam Al-Warafi (M.S), Supervisor. Piperazine sulfonamides: synthesis, characterization, and in vitro biological evaluation as potential DPP-IV inhibitors, 2018/2019. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Bara’a Al-Nawaiseh (M.S), Supervisor. Halogenated benzamides: synthesis and in vitro study as potential cholesteryl ester transfer protein (CETP) inhibitors, 2018/2019. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Sara Mefleh (M.S), Supervisor. Synthesis and biological evaluation of novel hydrazone derivatives as potential dipeptidyl peptidase-4 inhibitors, 2017/2018. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Shorouq  Al-Qazaqi (M.S), Supervisor. Synthesis and Biological Evaluation of sulfonamide derivatives as new DPPIV inhibitors, 2017/2018. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Maram Abu Rezeq (M.S), Supervisor. Synthesis, spectroscopic characterization and biological evaluation of phenanthridine derivatives as potential DPP-IV  inhibitors, 2017/2018. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Hazar Ahmad Yousef (M.S), Examiner. Structure-based modeling to search for new anaplastic lymphoma kinase (ALK) inhibitors, 2017. Faculty of Pharmacy/Applied Science University.

 

  • Shaima’a Emad Hasan (M.S), Supervisor. Design, Synthesis, and Biological Evaluation of N-Substituted-4-Hydroxy-6-Methyl-2-Quinolone-3-Carboxamides as PI3Kα Inhibitors, 2016/2017. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Samer M. Abu-Joudah (M.S), Examiner. The use of structure-based modeling and in vitro assay for the exploration of new spleen tyrosine kinase inhibitors, 2017. Faculty of Pharmacy/Applied Science University.

 

  • Ala’a abuRezeq (M.S), Examiner. Development and Optimization of Oleogels and Bigels as Topical Drug Delivery Systems for Periodontitis, 1/2017. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Haya Abu Jarad (M.S), Supervisor. Synthesis and Biological Evaluation of Piperazine Derivatives as DPP-IV Inhibitors, 2016/2017. Faculty of      Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Nisreen Sha’aban Hamadah (M.S), Examiner. Optimization of 4-hydroxy-2-quinolone-3-carboxamide core nucleus targeting PI3Kα inhibition, 2016/2017. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Haneen Muneer Abuzaid (M.S), Examiner. Design, Synthesis and In Vivo Biological Evaluation of Imidazole-5-Carboxamide Derivatives as Lipoprotein Lipase Activators, 8/2016. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Ameerah Said Hasan Ibrahim (M.S), Examiner. Optimization and Synthesis of Benzoin Derivatives as PI3Kα Inhibitors, 6/2016. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Fatima Mahmoud Al-Tarawneh (M.S), Examiner. Design, Synthesis, and Biological Evaluation of Benzoin Schiff’s Bases as Antitumor Agents, 5/2016. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Sajeda Ali Salah (M.S), Examiner. Discovery of new Gyrase B inhibitors via structure based modeling, 2016. Faculty of Pharmacy/Applied Science University.

 

  • Nisreen Nazmi ”Haj Ahmad” (M.S), Supervisor. Synthesis and Antihyperlipidemic Properties of Novel N-(4-Benzoylphenyl) Pyrrole-2-Carboxamide Derivatives, 1/2016. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Areej Khalil Nasserallah (M.S), Supervisor. Synthesis and Biological Evaluation of Benzylamino Benzamide Derivatives as Potential CETP Inhibitors, 2015/2016. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Sarah Al-Rawashdeh (M.S), Supervisor. Fluorinated Benzamides: Design, Synthesis and Biological Evaluation as Potential CETP Inhibitors, 2014/2015. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Dalal Al-Masalha (M.S), Supervisor. Phenanthridines: Design, Synthesis and Biological Evaluation as Potential DPP-IV Inhibitors, 2014/2015. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Musaab Saada (M.S), Supervisor. Pharmacophore-Based Screening and Identification of Novel Phosphoinosited 3-Kinase (PI3Kα) Inhibitors, 2013/2014. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Bayan Salah Hishmah (M.S), Examiner. Design, Synthesis and Biological Evaluation of Novel PI3K Alpha Inhibitors, 12/2014. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Hamadah Abd-ElAziz (M.S), Supervisor. Synthesis and biological evaluation of substituted fluorinated alkyloxy benzylamino benzenamide as potential CETP inhibitors, 2013/2014. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Zainab Ali Jarekji (M.S), Supervisor. Design, Synthesis and Biological Evaluation of a New Series of Potential DPP IV Inhibitors, 2012/2013. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

 

  • Mohammed Alhindi (M.S), Supervisor. Design, Synthesis and Biological Evaluation of a New Series of Potential CETP Inhibitors, 2012/2013. Faculty of Pharmacy/Al-Zaytoonah University of Jordan.

Comments are closed.

Thanks for downloading!

Top